Share this article on:

Management of high blood pressure in children and adolescents: recommendations of the European Society of Hypertension

Lurbe, Empara,b; Cifkova, Renatac; Cruickshank, J Kennedyd; Dillon, Michael Je; Ferreira, Isabelf; Invitti, Ceciliag; Kuznetsova, Tatianah; Laurent, Stephanei; Mancia, Giuseppej; Morales-Olivas, Franciscok; Rascher, Wolfgangl; Redon, Josepb,m; Schaefer, Franzn; Seeman, Tomaso; Stergiou, Georgep; Wühl, Elken; Zanchetti, Albertoq

doi: 10.1097/HJH.0b013e32832f4f6b

Hypertension in children and adolescents has gained ground in cardiovascular medicine, thanks to the progress made in several areas of pathophysiological and clinical research. These guidelines represent a consensus among specialists involved in the detection and control of high blood pressure in children and adolescents. The guidelines synthesize a considerable amount of scientific data and clinical experience and represent best clinical wisdom upon which physicians, nurses and families should base their decisions. They call attention to the burden of hypertension in children and adolescents, and its contribution to the current epidemic of cardiovascular disease, these guidelines should encourage public policy makers, to develop a global effort to improve identification and treatment of high blood pressure among children and adolescents.

aDepartment of Pediatrics, Consorcio Hospital General, University of Valencia, Valencia, Spain

bCIBER Fisiopatología Obesidad y Nutrición (CB06/03), Instituto de Salud Carlos III, Madrid, Spain

cDepartment of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic

dManchester Royal Infirmary Cardiovascular Research Group, Division of Cardiovascular & Endocrine Science, University of Manchester, Manchester, UK

eNephro-Urology Unit, UCL Institute of Child Health, London, UK

fDepartment of Internal Medicine and of Clinical Epidemiology and Medical Technology Assessment, Cardiovascular Research Institute Maastricht (CARIM), Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Centre, Maastricht, The Netherlands

gUnit of Metabolic Diseases and Diabetes, Istituto Auxologico Italiano, IRCCS, Milan, Italy

hLaboratory of Hypertension, University of Leuven, Leuven, Belgium

iPharmacology Department, Hopital Europeen Georges Pompidou, Paris, France

jUniversity of Milano-Bicocca, Ospedale SanGerardo, Milan, Italy

kDepartment of Pharmacology, University of Valencia, Valencia, Spain

lKinder-und Jugendklinik, Universitätsklinikum, Erlangen, Germany

mDepartment of Internal Medicine, Hospital Clinico, University of Valencia, Valencia, Spain

nDivision of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany

oDepartment of Pediatrics, University Hospital Motol, Charles University, Prague, Czech Republic

pHypertension Center, Third University Department of Medicine, Sotiria Hospital, Athens, Greece

qCentro Interuniversitario di Fisiologia Clinica e Ipertensione, Università di Milano and Istituto Auxologico Italiano, Milan, Italy

Received 2 June, 2009

Accepted 9 June, 2009

Correspondence to Empar Lurbe, MD, Department of Pediatrics, Consorcio Hospital General, University of Valencia, Avda Tres Cruces s/n. 46014, Valencia, Spain Fax: +34 96 3862647; e-mail:

© 2009 Lippincott Williams & Wilkins, Inc.